494.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$491.53
Aprire:
$496.3
Volume 24 ore:
1.50M
Relative Volume:
0.66
Capitalizzazione di mercato:
$183.71B
Reddito:
$44.56B
Utile/perdita netta:
$6.72B
Rapporto P/E:
27.88
EPS:
17.7387
Flusso di cassa netto:
$6.29B
1 W Prestazione:
+0.77%
1M Prestazione:
-5.10%
6M Prestazione:
-6.82%
1 anno Prestazione:
+2.40%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development - PharmiWeb.com
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026 - pharmiweb.com
Smarter Raman QC for biopharma fill-finish with scalable model transfer - europeanpharmaceuticalreview.com
Live Cell Imaging Market Set to Boom Rapidly by 2033| Thermo Fisher Scientific Inc. • Merck KgaA • PerkinElmer Inc - openPR.com
Before markets open, Thermo Fisher posts Q1 results on April 23 - Stock Titan
Rockland Trust Co. Has $34.27 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Experiences Revision in Stock Evaluation Amid Market Volatility - marketsmojo.com
[Form 4] THERMO FISHER SCIENTIFIC INC. Insider Trading Activity - Stock Titan
Thermo Fisher (NYSE: TMO) director receives 66 Phantom Stock Units as deferred pay - Stock Titan
Thermo Fisher (NYSE: TMO) director granted 66.02 phantom stock units - Stock Titan
Thermo Fisher (NYSE: TMO) director adds 66 Phantom Stock Units under deferred plan - Stock Titan
Thermo Fisher (NYSE: TMO) director adds phantom stock units grant - Stock Titan
Thermo Fisher Scientific Stock: Leading Life Sciences Provider Faces Mixed Institutional Flows Amid - AD HOC NEWS
Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM - The Joplin Globe
Northstar Advisory Group LLC Acquires Shares of 5,609 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Position Trimmed by James Hambro & Partners LLP - MarketBeat
J. Safra Sarasin Holding AG Lowers Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Mn Services Vermogensbeheer B.V. Has $84.72 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
How is Thermo Fisher (TMO) Preparing to Deal With Rising Helium Prices - Insider Monkey
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Thermo Fisher Scientific Stock Hits Day Low Amid Price Pressure at $472.08 - Markets Mojo
Thermo Fisher Scientific (TMO) Sets Stage for Q4 Rally with Impressive Q3 Earnings and New 52-Week High - Insider Monkey
U.S. Automated Analyzer Market Is Going to Boom| Thermo Fisher - openPR.com
Thermo Fisher (TMO) Shares Up Since Jim Cramer Called the Firm “Unbelievable” - Insider Monkey
Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook - GlobeNewswire Inc.
Food Testing Kits Market Is Going to Boom | Thermo Fisher Scientific • Eurofins Scientific • SGS SA - openpr.com
Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Canoe Financial LP Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Assenagon Asset Management S.A. Has $6.22 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Generate Investment Management Ltd Has $20.66 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC - National Today
Eagle Rock Investment Company LLC Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by DAVENPORT & Co LLC - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Moved Down by 3.31% on Mar 27: What Investors Need To Know - TradingKey
Vanguard Amends 13G: Reports 0 Shares in Thermo Fisher (TMO) - stocktitan.net
Thermo Fisher Scientific collaborates with SHL Medical and expands Ridgefield site - ROI-NJ
Thermo Fisher Scientific (NYSE:TMO) Earns Buy Rating from Analysts at DZ Bank - MarketBeat
What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release - Barchart.com
Thermo Fisher and SHL Medical collaborate to deliver fully integrated drug-device solutions - BioSpectrum Asia
Is Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now? - MSN
Is Thermo Fisher Scientific (TMO) One of the Best Conservative Stocks to Buy Right Now? - Yahoo Finance
U.S. Sterility Testing Market Set to Boom Rapidly by 2033 | Thermo - openPR.com
Czech National Bank Purchases 3,163 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
CCM Investment Advisers LLC Sells 2,163 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Sci. stock faces pressure amid life sciences slowdown and acquisition scrutiny as of M - AD HOC NEWS
Thermo Fisher, SHL Medical collab on drug delivery device production - Drug Delivery Business
Thermo Fisher and SHL Medical partner on integrated drug device solutions - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions - BioSpace
Thermo Fisher completes $8.9B buyout of Clario - medtechdive.com
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):